AVeta Medical Names Karen Noblett, M.D., as Chief Executive Officer

Galway, Ireland, December 17, 2025 (Business Wire) -- AVeta Medical announced the appointment of Karen Noblett, M.D., as Chief Executive Officer, marking a leadership transition as the company advances its VITA AV™ platform for genitourinary syndrome of menopause. Noblett joins from Axonics, where she served as Chief Medical Officer and led clinical strategy, regulatory programs, and physician education supporting the global adoption of sacral neuromodulation technologies. Eileen Duffy, who served as interim CEO, has been named Chair of the Board, while the company positions itself for its next phase of clinical, regulatory, and commercial growth in women’s health.

Read full article here.